Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML

Bone Marrow Transplant. 2023 Mar;58(3):328-331. doi: 10.1038/s41409-022-01877-2. Epub 2022 Nov 29.

¹ Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA. pthomas@wustl.edu.
² Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
³ Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
⁴ Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
⁵ Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA. swati.naik@stjude.org.

No abstract available

Publication types